why choose us

First received: January 24, 2024

Clinical Trial: Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Schizophrenia

Study Type: INTERVENTIONAL


Official Title: A Randomized Controlled Trial to Evaluate Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Brief Summary: Schizophrenia is a serious mental disorder with a global prevalence of 1%.The main cause of this condition is dysfunction in the signaling of neurotransmitters dopamine, serotonin, glutamate and Gamma-aminobutyric acid .According to recent research, a disturbed cellular energy state caused by mitochondrial dysfunction is thought to be a factor in the development of schizophrenia.The aim of the treatment of schizophrenia is to reduce symptoms and is mainly based on the monoamine hypothesis.Atypical antipsychotics…

Read more